P. Trimoulet

F. Ceccherini‐Silberstein, H. Fleury, F. Mazzotta, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.

M. Houghton, D. Neau, J. Ragnaud, 2002, The Journal of infectious diseases.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

N. Schnepf, P. Colson, P. Trimoulet, 2013, Virology Journal.

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2013, The Journal of general virology.

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

Domenico Di Carlo, F. Ceccherini‐Silberstein, H. Fleury, 2017, Oncotarget.

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection.

B. Berkhout, H. Fleury, M. Andreoni, 2015, The Journal of infection.

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.

F. Ceccherini‐Silberstein, H. Fleury, M. Levrero, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia

H. Fleury, P. Trimoulet, H. Triki, 2015, Virology Journal.

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

F. Ceccherini‐Silberstein, H. Fleury, M. Andreoni, 2018, Viruses.

A European multicenter study on the analytical performance of the VERIS HBV assay.

A. Lombardi, H. Fleury, J. Izopet, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study

P. Couzigou, P. Marcellin, J. Pawlotsky, 2005, Journal of viral hepatitis.

No evidence of sexual transmission of HEV among individuals using HIV pre‐exposure prophylaxis

J. Izopet, P. Delobel, P. Trimoulet, 2020, Journal of viral hepatitis.

Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation

V. de Lédinghen, S. Lepreux, N. Kamar, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

V. de Lédinghen, P. Couzigou, B. le Bail, 2011, Alimentary pharmacology & therapeutics.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia

H. Fleury, P. Trimoulet, H. Triki, 2015, Virology Journal.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

Dynamic and Rapid Changes in Viral Quasispecies by Udps in Chronic Hepatitis C Patients Receiving Telaprevir-Based Therapy

V. de Lédinghen, H. Fleury, M. Kann, 2013, Antiviral therapy.

Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy

V. de Lédinghen, P. Couzigou, H. Fleury, 2004, Journal of medical virology.

Intrahepatic HCV RNA loads in 37 HIV‐HCV co‐infected patients with controlled HIV infection

D. Neau, J. Ragnaud, M. Dupon, 2002, Journal of medical virology.

Epidemiological and phylogenetic evidence for patient‐to‐patient hepatitis C virus transmission during sclerotherapy of varicose veins

V. de Lédinghen, P. Couzigou, H. Fleury, 2005, Journal of medical virology.

Hepatitis C virus (HCV) protease variability and anti‐HCV protease inhibitor resistance in HIV/HCV‐coinfected patients

D. Neau, J. Ragnaud, M. Dupon, 2011, HIV Medicine.

Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world.

V. de Lédinghen, F. Zoulim, D. Ouzan, 2017, Journal of hepatology.

TT virus infection during chronic hepatitis C

P. Couzigou, H. Fleury, D. Ekouevi, 2000, American Journal of Gastroenterology.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Hepatitis C Virus Genotyping Based on 5′ Noncoding Sequence Analysis (Trugene)

V. de Lédinghen, P. Couzigou, D. Ouzan, 2001, Journal of Clinical Microbiology.

Noncoding Sequence Analysis ( Trugene ) ′ Hepatitis C Virus Genotyping Based on 5

P. Couzigou, D. Ouzan, H. Fleury, 2001 .

Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication.

H. Fleury, P. Trimoulet, A. Cahour, 2008, The Journal of general virology.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

P. André, J. Pawlotsky, J. Izopet, 2017, PloS one.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

P. André, J. Pawlotsky, S. Bertrais, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evaluation of the VERSANT HCV RNA 3.0 Assay for Quantification of Hepatitis C Virus RNA in Serum

H. Fleury, G. Chêne, P. Trimoulet, 2002, Journal of Clinical Microbiology.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.

V. de Lédinghen, V. Paradis, B. Autran, 2020, Journal of hepatology.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France

H. Wodrich, D. Malvy, P. Trimoulet, 2022, Journal of Clinical Virology.

Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.

H. Fleury, M. Kann, W. Gerlich, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay.

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

European Multicenter Study on Analytical Performance of Veris HIV-1 Assay

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of Clinical Microbiology.

Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome.

J. Viallard, J. Pellegrin, P. Trimoulet, 2000, The Journal of rheumatology.

Recurrence and Accelerated Progression of Hepatitis C following Liver Transplantation

B. le Bail, C. Balabaud, P. Bioulac-Sage, 2000, Seminars in liver disease.

Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C

V. de Lédinghen, P. Couzigou, D. Breilh, 2009, Alimentary pharmacology & therapeutics.

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.

D. Neau, J. Ragnaud, M. Dupon, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute hepatitis associated with hepatitis G virus primo-infection in a renal transplant recipient.

H. Fleury, P. Trimoulet, P. Merville, 2004, Transplantation.

A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit.

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatic steatosis in HIV‐HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype

V. de Lédinghen, D. Neau, F. Dabis, 2007, Alimentary pharmacology & therapeutics.

Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

P. Marcellin, G. Duverlie, P. Trimoulet, 2019, Epidemiology and Infection.

Interferon‐gamma with peginterferon alpha‐2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)

P. Couzigou, P. Marcellin, G. Chêne, 2013, Journal of gastroenterology and hepatology.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits

J. Pawlotsky, G. Duverlie, J. Izopet, 2011, Journal of Clinical Microbiology.

Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.

D. Breilh, D. Neau, J. Ragnaud, 2009, Journal of acquired immune deficiency syndromes.

Independent validation and comparison with fibroscan, fibrotest and liver biopsy of clinical glycomics for the non invasive assessment of liver fibrosis in chronic hepatitis C

R. Contreras, P. Couzigou, N. Callewaert, 2005 .

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay

Jordi Vila, Patrick Braun, Rafael Delgado, 2017, Journal of Clinical Microbiology.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

P. Couzigou, P. Marcellin, G. Chêne, 2010, Journal of medical virology.

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

J. Pawlotsky, G. Duverlie, J. Izopet, 2007, Journal of Clinical Microbiology.